- Tytuł:
- Immunogenicity and safety of SARS-CoV-2 recombinant protein nanoparticle vaccine GBP510 adjuvanted with AS03: interim results of a randomised, active-controlled, observer-blinded, phase 3 trial
- Autorzy:
- Źródło:
- In eClinicalMedicine October 2023 64
Czasopismo naukowe